Leukopenia with High Monocytes: Causes and Treatment Approaches

Common Causes

• The European Hematology Association notes that chronic myelomonocytic leukemia (CMML) is most commonly associated with leukopenia with high monocytes, characterized by persistent peripheral blood monocytosis with features of both myeloproliferative neoplasm and myelodysplastic syndrome 1
• The American Society of Clinical Oncology recommends considering acute myelomonocytic leukemia as a cause of leukopenia with relative monocytosis, often presenting with leukopenia and relative monocytosis 2
• The American College of Rheumatology states that systemic lupus erythematosus can present with autoimmune leukopenia 5

Diagnostic Approach

• The International Society for Laboratory Hematology recommends bone marrow aspiration and biopsy as essential for diagnosing hematologic malignancies, particularly for CMML and other myeloid disorders 6
• The American Society for Clinical Pathology suggests cytogenetic analysis, particularly important for CMML and other myeloid disorders 6
• The European Society for Medical Oncology notes that flow cytometry is useful to characterize abnormal cell populations 4

Treatment Approaches

• The National Comprehensive Cancer Network recommends supportive therapy focused on correcting cytopenias for myelodysplastic-type CMML with <10% blasts, including erythropoietic stimulating agents for severe anemia and myeloid growth factors for febrile severe neutropenia 6
• The American Society of Hematology suggests hypomethylating agents (5-azacytidine or decitabine) for myelodysplastic-type CMML with ≥10% blasts 6
• The European Society for Medical Oncology recommends cytoreductive therapy with hydroxyurea as first-line treatment for myeloproliferative-type CMML with <10% blasts 6, 7
• The American Society of Clinical Oncology recommends induction chemotherapy with anthracycline and cytosine arabinoside for acute myeloid leukemia, with consolidation therapy based on risk stratification 2, 8
• The International Society for Laboratory Hematology notes that allogeneic stem cell transplantation is the only curative option for many hematologic malignancies causing leukopenia with monocytosis, particularly indicated for CMML in selected patients, AML with poor risk features, and CLL with very high risk features or refractory disease 6, 7

Monitoring and Follow-up

• The American Society for Clinical Pathology recommends regular complete blood counts to monitor response to treatment, and bone marrow evaluation to assess disease status in hematologic malignancies 2, 6

Special Considerations

• The European Hematology Association notes that age and comorbidities significantly impact treatment decisions, particularly regarding intensive chemotherapy and transplantation eligibility 2, 6